Intellia Therapeutics (NTLA) Tax Rate (2015)
Intellia Therapeutics (NTLA) reported Tax Rate of 4.48% for Q4 2015, down 47.56% on a QoQ basis from 8.54% in Q3 2015.
Intellia Therapeutics (NTLA) has 1 years of Tax Rate data on file, last reported at 4.48% in Q4 2015.
- Quarterly Tax Rate changed N/A year-over-year to 4.48% in Q4 2015, while the trailing twelve-month figure through Sep 2016 was 0.93% (changed N/A YoY) and the FY2015 annual result came in at 7.55%, changed N/A from the prior year.
- Tax Rate slipped to 4.48% in Q4 2015 per NTLA's latest filing, from 8.54% in the prior quarter.
- Across five years, Tax Rate topped out at 11.16% in Q2 2015 and bottomed at 4.48% in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 4.48 |
| Dec 31, 2015 | 4.48 |
| Sep 30, 2015 | 8.54 |
| Sep 30, 2015 | 8.54 |
| Jun 30, 2015 | 11.16 |
| Jun 30, 2015 | 11.16 |
| Mar 31, 2015 | 8.54 |
| Mar 31, 2015 | 8.54 |